Clinical factors associated with satisfaction of cancer patients for the treatment of opioid-induced constipation: A post hoc analysis utilizing outcomes of naldemedine phase III study

被引：0
|
作者：
Ishiki, H. [1 ]
Satomi, E. [1 ]
Tada, Y. [2 ]
Yokota, T. [3 ]
Sato, H. [4 ]
Okamoto, M. [5 ]
Osaka, I. [6 ]
机构：
[1] Natl Canc Ctr, Dept Palliat Med, Tokyo, Japan
[2] Shionogi & Co Ltd, Biostat Ctr, Osaka, Japan
[3] Shionogi & Co Ltd, Global Project Management, Osaka, Japan
[4] Shionogi & Co Ltd, Global Med Affairs, Osaka, Japan
[5] Shionogi & Co Ltd, Med Affairs, Osaka, Japan
[6] Shizuoka Canc Ctr, Dept Palliat Med, Shizuoka, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
424P
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [41] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Chronic Non-Cancer Pain
    Webster, Lynn Roy
    Yamada, Tadaaki
    Ferreira, Juan Camilo Arjona
    Davidson, Jennifer
    GASTROENTEROLOGY, 2015, 148 (04) : S1194 - S1194
  • [42] Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis
    Yuko Kanbayashi
    Yuichi Ishizuka
    Mayumi Shimizu
    Shohei Sawa
    Katsushige Yabe
    Mayako Uchida
    Supportive Care in Cancer, 2022, 30 : 5831 - 5836
  • [43] Risk factors for opioid-induced constipation in cancer patients: a single-institution, retrospective analysis
    Kanbayashi, Yuko
    Ishizuka, Yuichi
    Shimizu, Mayumi
    Sawa, Shohei
    Yabe, Katsushige
    Uchida, Mayako
    SUPPORTIVE CARE IN CANCER, 2022, 30 (07) : 5831 - 5836
  • [44] Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Subjects With Chronic Non-Cancer Pain Receiving Opioid Therapy: Results From Two Phase 3 Clinical Trials
    Hale, Martin E.
    Wild, James
    Reddy, Jyotsna
    Yamada, Tadaaki
    Ferreira, Juan Camilo Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S121 - S122
  • [45] Naldemedine and Magnesium Oxide as First-Line Medications for Opioid-Induced Constipation: A Comparative Database Study in Japanese Patients With Cancer Pain
    Kessoku, Takaomi
    Higashibata, Takahiro
    Morioka, Yasuhide
    Naya, Noriyuki
    Koretaka, Yuichi
    Ichikawa, Yasushi
    Hisanaga, Takayuki
    Nakajima, Atsushi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [46] Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study
    Masanori Mori
    Yongli Ji
    Santosh Kumar
    Takamaru Ashikaga
    Steven Ades
    International Journal of Clinical Oncology, 2017, 22 : 397 - 404
  • [47] Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study
    Mori, Masanori
    Ji, Yongli
    Kumar, Santosh
    Ashikaga, Takamaru
    Ades, Steven
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (02) : 397 - 404
  • [48] Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation in cancer patients.
    Mori, M.
    Ashikaga, T.
    Grunberg, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain
    Webster, Lynn R.
    Brenner, Darren M.
    Barrett, Andrew C.
    Paterson, Craig
    Bortey, Enoch
    Forbes, William P.
    JOURNAL OF PAIN RESEARCH, 2015, 8 : 771 - 780
  • [50] Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes
    Coyne, Karin S.
    Poon, Jiat-Ling
    Thompson, Christine
    Hu, Yiqun
    Datto, Catherine J.
    Sostek, Mark
    CLINICAL THERAPEUTICS, 2017, 39 (01) : 75 - 88
12345